
DEEP TRACK CAPITAL, LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GERN | 41.10M | $56.30M |
![]() | DVAX | 15.73M | $156.16M |
![]() | OCUL | 11.93M | $139.49M |
![]() | IMVT | 9.73M | $156.83M |
![]() | ETNB | 9.36M | $137.54M |
![]() | APLS | 8.00M | $181.05M |
![]() | CMPS | 7.86M | $45.04M |
![]() | TERN | 7.50M | $56.29M |
![]() | CNTX | 7.42M | $7.19M |
![]() | NRIX | 6.06M | $55.97M |
![]() | VRDN | 5.38M | $116.11M |
![]() | CYTK | 4.30M | $236.33M |
![]() | GPCR | 4.22M | $118.04M |
![]() | GH | 4.15M | $259.55M |
![]() | AKRO | 4.00M | $189.97M |
![]() | MAZE | 3.95M | $102.40M |
![]() | IONS | 3.81M | $249.13M |
![]() | OLMA | 3.47M | $33.97M |
![]() | MBX | 3.15M | $55.13M |
![]() | PCVX | 3.00M | $108.06M |

Geron Corporation
GERN
Shares Held
41.10M
Value
$56.30M

Dynavax Technologies Corporation
DVAX
Shares Held
15.73M
Value
$156.16M

Ocular Therapeutix, Inc.
OCUL
Shares Held
11.93M
Value
$139.49M

Immunovant, Inc.
IMVT
Shares Held
9.73M
Value
$156.83M

89bio, Inc.
ETNB
Shares Held
9.36M
Value
$137.54M

Apellis Pharmaceuticals, Inc.
APLS
Shares Held
8.00M
Value
$181.05M

COMPASS Pathways plc
CMPS
Shares Held
7.86M
Value
$45.04M

Terns Pharmaceuticals, Inc.
TERN
Shares Held
7.50M
Value
$56.29M

Context Therapeutics Inc.
CNTX
Shares Held
7.42M
Value
$7.19M

Nurix Therapeutics, Inc.
NRIX
Shares Held
6.06M
Value
$55.97M

Viridian Therapeutics, Inc.
VRDN
Shares Held
5.38M
Value
$116.11M

Cytokinetics, Incorporated
CYTK
Shares Held
4.30M
Value
$236.33M

Structure Therapeutics Inc.
GPCR
Shares Held
4.22M
Value
$118.04M

Guardant Health, Inc.
GH
Shares Held
4.15M
Value
$259.55M

Akero Therapeutics, Inc.
AKRO
Shares Held
4.00M
Value
$189.97M

Maze Therapeutics, Inc.
MAZE
Shares Held
3.95M
Value
$102.40M

Ionis Pharmaceuticals, Inc.
IONS
Shares Held
3.81M
Value
$249.13M

Olema Pharmaceuticals, Inc.
OLMA
Shares Held
3.47M
Value
$33.97M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
3.15M
Value
$55.13M

Vaxcyte, Inc.
PCVX
Shares Held
3.00M
Value
$108.06M
